株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

性感染症診断検査市場(試験所検査、ポイントオブケア検査、試験所設備および備品) - 世界の業界分析、規模、シェア、成長、動向および予測(2013〜2019年)

Diagnostic Testing of STDs Market (Laboratory Testing, Point-Of-Care Testing, Laboratory Equipment and Supplies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 284517
出版日 ページ情報 英文 87 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
性感染症診断検査市場(試験所検査、ポイントオブケア検査、試験所設備および備品) - 世界の業界分析、規模、シェア、成長、動向および予測(2013〜2019年) Diagnostic Testing of STDs Market (Laboratory Testing, Point-Of-Care Testing, Laboratory Equipment and Supplies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2013年09月30日 ページ情報: 英文 87 Pages
概要

当レポートでは、性感染症診断検査市場について調査し、同市場の概要と分類、各セグメントの2013〜2019年の予測と成長率、地域別動向などをまとめ、概略下記の構成で取り上げております。

第1章 序論

第2章 エグゼクティブサマリー

第3章 イントロダクション:性感染症診断検査

  • 定義
  • 性感染症の重大性、コントロールおよび予防
  • 診断検査の種類

第4章 世界の性感染症診断検査市場概要

  • 概要
  • 促進因子
    • 性感染症の罹患率、発症率の上昇
    • 国のスクリーニングプログラム導入
    • 好ましい償還動向
  • 阻害因子
    • 任意の検査に伴う不名誉
    • 感染した患者の大多数が手の届かない地域にいる
    • 市場参入企業に対する厳格な法的順守要件
  • 機会
    • 地域のスクリーニングプログラム
    • 性感染症専用クリニックへの訪問減少
    • アジア太平洋地域およびその他の市場
  • 市場魅力度分析:地域別
  • 第5章 世界の性感染症診断検査市場:種類別(2013〜2019年)
  • クラミジア検査
  • 淋病検査
  • 梅毒検査
  • HPV検査
  • HSV検査
  • HIV検査
  • 軟性下疳検査
  • 試験所設備・備品市場

第6章 世界の性感染症診断検査市場:場所別(2013〜2019年)

  • 試験所検査
  • ポイントオブケア検査

第7章 世界の性感染症診断検査市場:地域別(2013〜2019年)

  • イントロダクション
  • クラミジア検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年
  • 淋病検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年
  • 梅毒検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年
  • HPV検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年
  • HSV検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年
  • HIV検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年
  • 軟性下疳検査(北米、欧州、アジア太平洋地域、およびその他)市場規模:2013年および2019年

第8章 提言

  • 国のスクリーニングプログラムに参画するための資格確保のための認定取得
  • 先進国における試験所インフラストラクチャーへの投資
  • アジア太平洋地域およびその他の地域への投資

第9章 企業プロファイル

  • Roche Holdings AG
  • Alere, Inc.
  • Becton Dickinson & Company
  • bioMerieux
  • Danaher Corporation
  • Hologic, Inc.

第10章 付録

図表

目次

Description

Sexually Transmitted Diseases (STDs) are diseases that spread primarily through person-to-person sexual contact. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of 'diagnostic testing of STDs'. The location where diagnostic tests are delivered i.e. in the laboratories or at the point-of-care (POC) also comprises the definition of 'diagnostic testing of STDs'. This report studies the market for diagnostic testing of STDs from the point of view of the testing services offered in the market in terms of testing volume and value. The overall diagnostic testing of STDs market is classified into Chlamydia testing, Gonorrhea testing, P&S Syphilis testing, HPV testing, HSV testing, HIV testing and Chancroid testing. The diagnostic testing of STDs market is also studied from the aspect of location or point of delivery of testing i.e. at laboratories or at the POC. The market size and forecast for the period 2013 - 2019, in terms of USD million, considering 2012 as the base year has been provided for each segment in the report. The compound annual growth rate (CAGR) for each segment has been provided for the forecast period from 2013 - 2019.

Geographically, the market for diagnostic testing of STDs has been classified into four regions - North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region along with their market growth rate has been highlighted. The market overview section of the report comprises of a qualitative analysis of the market in terms of drivers, restraints and opportunities, along with market attractiveness analysis.

The report concludes with the competitive landscape and company profiles of few market players in this industry, as of 2012. The market players profiled in this report include Roche Diagnostics, Alere, Orasure, Becton, Dickinson and Company, Biomerieux SA, Beckman Coulter, Inc. and Gen-Probe Inc.

The Global Diagnostic Testing of STDs market is segmented as follows:

Diagnostic Testing of STDs Market, by STD type

  • Chlamydia testing
  • Gonorrhea testing
  • P&S Syphilis testing
  • Human Papilloma Virus (HPV) testing
  • Herpes Simplex Virus (HSV) testing
  • Human Immunodeficiency Virus (HIV) testing
  • Chancroid testing

Diagnostic Testing of STDs Market, by Location

  • Laboratory Testing
  • Point-Of-Care (POC) Testing

Diagnostic Testing of STDs Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Introduction

  • 3.1 Definition - Diagnostic Testing of STDs
  • 3.2 Significance Of Stds, STDs Control And Prevention
  • 3.3 Types Of Diagnostic Tests Of STDs

Chapter 4 Global Diagnostic Testing of STDs Market Overview

  • 4.1 Overview
  • 4.2 Drivers
    • 4.2.1 Increasing Prevalence and Incidence Rates of STDs
    • 4.2.2 Favorable Reimbursments for STDs Testing
    • 4.2.3 National Screening Programs Implemented
  • 4.3 Restraints
    • 4.3.1 Stigma Associated with Volumtary STD Testing at STD Clinics
    • 4.3.2 Large Proportion of STD Infected Patients in Out-Of-Reach Geographic Areas
    • 4.3.3 Regulatory Compliance Needs for Market Participants
  • 4.4 Opportunities
    • 4.4.1 STD Type Specific Opportunities in Geographic Regions
    • 4.4.2 Opportunity for Supplies and Equipment Providers
  • 4.5 Market Attractiveness Analysis: Global Diagnostic Testing of STDs Market, By Geography

Chapter 5 Diagnostic Testing of STDs Market, By STD Type, 2013 - 2019 (USD Million)

  • 5.1 Chlamydia Testing
  • 5.2 Gonorrhea Testing
  • 5.3 P&S Syphilis Testing
  • 5.4 HPV Testing
  • 5.5 HSV Testing
  • 5.6 HIV Testing
  • 5.7 Chancroid Testing

Chapter 6 Diagnostic Testing Of STDs Market, By Location, 2013 And 2019 (USD Million)

  • 6.1 Laboratory Testing
  • 6.2 Point-Of-Care (POC) Testing

Chapter 7 Diagnostic Testing of STDs Market, By Geography, 2013 - 2019 (USD Million)

  • 7.1 North America
  • 7.2 Europe
  • 7.3 Asia-Pacific
  • 7.4 Rest Of The World (Row)

Chapter 8 Recommendations

  • 8.1 Gain Accreditation to Ensure Qualification to Participate in Chlamydia, HPV Screening Programs in Developed Regions
  • 8.2 Investing in Asia-Pacific and RoW Markets
  • 8.3 Investment in Laboratory Infrastructure

Chapter 9 Company Profiles

  • 9.1 Roche Diagnostics
    • 9.1.1 Company Overview
    • 9.1.2 Financial Overview
    • 9.1.3 Product Portfolio
    • 9.1.4 Business Strategies
    • 9.1.5 Recent Developments
  • 9.2 Alere
    • 9.2.1 Company Overview
    • 9.2.2 Financial Overview
    • 9.2.3 Product Portfolio
    • 9.2.4 Business Strategies
    • 9.2.5 Recent Developments
  • 9.3 Orasure
    • 9.3.1 Company Overview
    • 9.3.2 Financial Overview
    • 9.3.3 Product Portfolio
    • 9.3.4 Business Strategies
    • 9.3.5 Recent Developments
  • 9.4 Becton, Dickinson And Company
    • 9.4.1 Company Overview
    • 9.4.2 Financial Overview
    • 9.4.3 Product Portfolio
    • 9.4.4 Business Strategies
    • 9.4.5 Recent Developments
  • 9.5 Biomerieux SA
    • 9.5.1 Company Overview
    • 9.5.2 Financial Overview
    • 9.5.3 Product Portfolio
    • 9.5.4 Business Strategies
    • 9.5.5 Recent Developments
  • 9.6 Beckman Coulter, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Overview
    • 9.6.3 Product Portfolio
    • 9.6.4 Business Strategies
    • 9.6.5 Recent Developments
  • 9.7 Gen-Probe Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Overview
    • 9.7.3 Product Portfolio
    • 9.7.4 Business Strategies
    • 9.7.5 Recent Developments

List of Figures

  • FIG. 1 Diagnostic Testing of STDs: Market Segmentation
  • FIG. 2 Global Diagnostic Testing of STDs Market, By STD Type, 2013 (USD Million)
  • FIG. 3 Market Attractiveness Analysis: Global Diagnostic Testing of STDs Market, By Geography
  • FIG. 4 Global Market for Chlamydia Testing, Volume (USD Million), 2011 - 2019
  • FIG. 5 Global Market for Gonorrhea Testing, Volume (USD Million), 2011 - 2019
  • FIG. 6 Global Market for P&S Syphilis Testing, Volume (USD Million), 2011 - 2019
  • FIG. 7 Global Market for HPV Testing, Volume (USD Million), 2011 - 2019
  • FIG. 8 Global Market for HSV Testing, Volume (USD Million), 2011 - 2019
  • FIG. 9 Global Market for HIV Testing, Volume (USD Million), 2011 - 2019
  • FIG. 10 Global Market for Chancroid Testing, Volume (USD Million), 2011 - 2019
  • FIG. 11 Comparative Analysis: North America Diagnostic Testing of STDs Market, 2013 And 2019 (%)
  • FIG. 12 Comparative Analysis: Europe Diagnostic Testing Of STDs Market, 2013 and 2019 (%)
  • FIG. 13 Comparative Analysis: Asia-Pacific Diagnostic Testing of STDs Market, 2013 and 2019 (%)
  • FIG. 14 Comparative Analysis: Row Diagnostic Testing of STDs Market, 2013 and 2019 (%)

List of Tables

  • TABLE 1 Market Snapshot: Global Diagnostic Testing Of STDs Market
Back to Top